CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
2.785
-0.195 (-6.54%)
Mar 31, 2025, 1:41 PM EDT - Market open
CureVac Market Cap
CureVac has a market cap or net worth of $624.71 million as of March 31, 2025. Its market cap has decreased by -17.22% in one year.
Market Cap
624.71M
Enterprise Value
447.31M
1-Year Change
-17.22%
Ranking
Category
Stock Price
$2.79
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $624.71M, a decrease of -93.65%. That is a compound annual growth rate of -44.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 668.46M | -12.61% |
| Dec 31, 2024 | 764.91M | -18.86% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |